Yi-Tzai Chen
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Cholinesterase and Neurodegenerative Diseases
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 5
-
- Cholinesterase and Neurodegenerative Diseases 3
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Bingfang Yan (10 shared papers)Dongfang Yang (5 shared papers)Liangran Guo (4 shared papers)Wei Lü (4 shared papers)Yajuan Li (2 shared papers)Aftab Ahmed (1 shared paper)Irene Panderi (1 shared paper)Dennis Pantazatos (1 shared paper)
- Journals
- Drug Metabolism and Pharmacokinetics (2 papers)ACS Nano (2 papers)Nucleic Acids Research (2 papers)Biochemical Pharmacology (2 papers)Materials Chemistry and Physics (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Yi-Tzai Chen
14 papers receiving 512 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 111
- Pharmacology 62
- Biomedical Engineering 227
- Materials Chemistry 176
- Pharmacology 64
Countries citing papers authored by Yi-Tzai Chen
This map shows the geographic impact of Yi-Tzai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Tzai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Tzai Chen more than expected).
Fields of papers citing papers by Yi-Tzai Chen
This network shows the impact of papers produced by Yi-Tzai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Tzai Chen. The network helps show where Yi-Tzai Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi-Tzai Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 276 | |
| 2 | 2009 | 50 | |
| 3 | 2012 | 42 | |
| 4 | 2019 | 34 | |
| 5 | 2015 | 33 | |
| 6 | 2012 | 28 | |
| 7 | 2015 | 17 | |
| 8 | 2012 | 17 | |
| 9 | 2017 | 12 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 1 |
About Yi-Tzai Chen
Yi-Tzai Chen is a scholar working on Oncology, Pharmacology, Pharmacology, Materials Chemistry and Molecular Biology, having authored 14 papers that have together received 517 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Nanoplatforms for cancer theranostics (2 papers), Epigenetics and DNA Methylation (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Gold and Silver Nanoparticles Synthesis and Applications (2 papers) and Advanced Nanomaterials in Catalysis (2 papers). The work is most often cited by research in Biomaterials (111 citations), Pharmacology (62 citations), Biomedical Engineering (227 citations), Materials Chemistry (176 citations) and Pharmacology (64 citations). Yi-Tzai Chen has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Bingfang Yan, Dongfang Yang, Liangran Guo, Wei Lü, Yajuan Li, Aftab Ahmed, Irene Panderi, Dennis Pantazatos, Navindra P. Seeram and Daniel B. Niesen. Their work appears in journals such as Drug Metabolism and Pharmacokinetics, ACS Nano, Nucleic Acids Research, Biochemical Pharmacology and Materials Chemistry and Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.